Press Releases

05/19/2021

International Vaccine Institute and FII Institute sign MOU to cooperate on scientific research and publication

The agreement is an effort to further scientific research in infectious diseases and make knowledge more accessible through advocacy and joint publications.   May 19, 2021 – SEOUL, South Korea, RIYADH, Saudi Arabia – The International Vaccine Institute (IVI) and the Future Investment Initiative Institute […]
05/31/2021

IVI to develop an adaptive Phase 1b/2a schistosomiasis vaccine clinical trial

May 31, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded a grant to IVI to develop an adaptive trial design protocol for a Phase 1b/2a clinical trial of a schistosomiasis vaccine.   […]
06/29/2021

IVI organizes ROK-Australia-ASEAN Vaccine Forum to promote inclusive and sustainable recovery from the COVID-19 pandemic

The ROK-Australia-ASEAN Vaccine Forum took place in hybrid live/virtual format with transmission from Seoul on June 29, 2021   June 29, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) organized, and the Republic of Korea’s Ministry of Foreign Affairs (MOFA) and […]
07/05/2021

IVI and KNUST establish collaborating center to conduct vaccine research and development for global health